Course Directors : Teaching Staff : Guest Lecturer: Local Organiser: ESTRO coordinators: Melissa Vanderijst and Marta Jayes, project managers (BEL)

Similar documents
Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)

Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)

ESTRO-CARO Teaching Course on Image-guided cervix radiotherapy - With a special focus on adaptive brachytherapy Hilton Hotel Toronto Toronto, Canada

Local Organiser: Madhup Rastogi, Radiation Oncologist, Ram Manohar Lohia Institute of Medical Sciences, Lucknow

The New ICRU/GEC ESTRO Report in Clinical Practice. Disclosures

Basic Concepts in Image Based Brachytherapy (GEC-ESTRO Target Concept & Contouring)

Image guided brachytherapy in cervical cancer Clinical Aspects

GYN Brachytherapy at General Hospital / Medical University of Vienna. Richard Pötter

Recent Advances and current status of radiotherapy for cervix cancer

GYN GEC-ESTRO/ICRU 89 Target Concept. Richard Pötter Medical University Vienna

Linking DVH-parameters to clinical outcome. Richard Pötter, Medical University of Vienna, General Hospital of Vienna, Austria

EMBRACE- Studien Analysen und Perspektiven

brachytherapy Medical University of Vienna, Vienna, Austria, November 2014 Educational Workshop 3-D image-guided adaptive

Comprehensive and Practical Brachytherapy March 04-8 March 2018, Ljubljana, Slovenia Day 1 Sunday 4 March 2018

MR-Guided Brachytherapy

CT Guided Contouring: Challenges and Pitfalls

Dose-Volume Histogram Analysis in Point A-based Dose Prescription of High-dose-rate Brachytherapy for Cervical Carcinoma

Outline - MRI - CT - US. - Combinations of imaging modalities for treatment planning

Index. T1 and T2-weighted images, 189

Version A European study on MRI-guided brachytherapy in locally advanced cervical cancer EMBRACE (ENDORSED BY GEC ESTRO)

3D ANATOMY-BASED PLANNING OPTIMIZATION FOR HDR BRACHYTHERAPY OF CERVIX CANCER

Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer

Advances in Image-guided Brachytherapy

Image guided adaptive brachytherapy in patients with cervical cancer

INTRODUCTION PATIENT. J. Radiat. Res., 52, (2011)

The Evolution of RT Techniques for Gynaecological Cancers in a developing country context

Role of MRI in Intracavitary Brachytherapy for Cervical Cancer: What the Radiologist Needs to Know

Preliminary reports. Primoz Petric, MD, MSc, Robert Hudej, PhD, Maja Music, MD. Abstract. Introduction

EMBRACE II: Accreditation and patient accrual

Comparison of rectal and bladder ICRU point doses to the GEC ESTRO volumetric doses in Cervix cancer


MRI in Cervix and Endometrial Cancer

GOROC POSITION PAPER ON IGBT FOR CERVICAL CANCER FACULTY OF RADIATION ONCOLOGY THE ROYAL AUSTRALIAN AND NEW ZEALAND COLLEGE OF RADIOLOGISTS

Brachytherapy in Africa

REVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria

CT Guided Contouring: Challenges and Pitfalls

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Utrecht Interstitial Applicator Shifts and DVH Parameter Changes in 3D CT-based HDR Brachytherapy of Cervical Cancer

INTRODUCTION TO BRACHYTHERAPY, HISTORY AND INDICATIONS. Christine Haie-Meder Brachytherapy Unit

presenting Brachytherapy with focus on Gynecological Cancers

Johannes C. Athanasios Dimopoulos

Image-guided adaptive brachytherapy in cervical cancer: Learning curve assessment. for the delineation of the clinical target volumes

Advances in Gynecologic Brachytherapy

Definitions. Brachytherapy in treatment of cancer. Implantation Techniques and Methods of Dose Specifications. Importance of Brachytherapy in GYN

Radiotherapy and Oncology

High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events

EMBRACE 9 th Annual Meeting. Bladder toxicity: Risk factors. Sofia Spampinato, Lars Fokdal, Jacob Lindegaard, Kari Tanderup, Richard Pötter

MRI Guided GYN Brachytherapy: Clinical Considerations

Enterprise Interest None

High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes

Intracavitary + Interstitial Techniques Rationale

Vagina. 1. Introduction. 1.1 General Information and Aetiology

Impact of Bladder Distension on Organs at Risk in 3D Intracavitary Brachytherapy for Cervical Cancer

Nordic Society for Gynecological Oncology Advisory Board of Radiotherapy

Specialised Services Clinical Access Policy: Enhanced Image Guided Brachytherapy (IGBT) Service for the Treatment of Gynaecological Malignancies

Modern Interstitial GYN Brachytherapy. Conflicts: 8/3/2016. Modern Interstitial GYN Brachytherapy. 1. Use of MR

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

NEWER RADIATION (3 D -CRT, IMRT, IGRT) TECHNIQUES FOR CERVICAL CANCERS (COMMON PELVIC TUMORS)

Interstitial Brachytherapy. Low dose rate brachytherapy. Brachytherapy alone cures some cervical cancer. Learning Objectives

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป

NIH Public Access Author Manuscript Int J Radiat Oncol Biol Phys. Author manuscript; available in PMC 2015 July 01.

HHS Public Access Author manuscript Gynecol Oncol. Author manuscript; available in PMC 2018 May 01.

PORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:

Staging and Treatment Update for Gynecologic Malignancies

A patient-based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix

EMBRACE I Data completeness Database dump

Basics of Cervix Cancer Brachytherapy

Locally advanced disease & challenges in management

PROSTATE CANCER BRACHYTHERAPY. Kazi S. Manir MD,DNB,PDCR RMO cum Clinical Tutor Department of Radiotherapy R. G. Kar Medical College

SYSTEMS IN BRACHYTHERAPY. Alfredo Polo MD, PhD Division of Human Health International Atomic Energy Agency

Basic Fundamentals & Tricks of the Trade for Intracavitary Radiotherapy for Cervix Cancer. Paula A. Berner, B.S., CMD, FAAMD

Challenging Cases in Cervical Cancer: Parametrial Boosting. Beth Erickson, MD, FACR, FASTRO Medical College Wisconsin

Partial Breast Irradiation using adaptive MRgRT

New research in prostate brachytherapy

Vaginal Dose, Toxicity and Sexual Outcomes in Patients of Cervical Cancer Undergoing Image Based Brachytherapy

Image based Brachytherapy- HDR applications in Gynecological Tumors

Uterine perforation 5-year experience in 3-D image guided gynaecological brachytherapy at Institute of Oncology Ljubljana

Adaptive radiotherapy strategies for pelvic tumors a systematic review of clinical implementations

ART for Cervical Cancer: Dosimetry and Technical Aspects

The Role of Radiation in the Management of Gynecologic Cancers. Scott Glaser, MD

The Use of Sectional Imaging with CT and MRI for Image-Guided Therapy

What is endometrial cancer?

Radiotherapy & Cervical Cancer Dr Mary McCormack Consultant Clinical Oncologist University College Hospital, London,UK

Comparison of high-dose-rate intracavitary brachytherapy dosimetry with and without anesthesia in patients with cervical carcinoma

Healthcare Professional Guide

Current Status of Image Guided Brachytherapy for Cervical Cancer In Japan

Educational Activity. Review paper. Abstract

Clinical implementation of multisequence MRIbased adaptive intracavitary brachytherapy for cervix cancer

Does conformal therapy improve dose distribution in comparison to old techniques in teleradiotherapy of cervical cancer patients?

Venezia Advanced Gynecological Applicator Reaching beyond

HDR Brachytherapy I: Overview of Clinical Application and QA. Disclosures. Learning Objectives 7/23/2014. Consultant, Varian Medical Systems

University of Alberta

La Pianificazione e I Volumi di Trattamento

Defining Target Volumes and Organs at Risk: a common language

Changing Paradigms in Radiotherapy

A B S T R A C T. 1. Introduction

Rotating-shield brachytherapy (RSBT) for cervical cancer

16 Primary Vaginal Cancer Alain Gerbaulet, Richard Pötter, Christine Haie-Meder

High-Dose-Rate Orthogonal Intracavitary Brachytherapy with 9 Gy/Fraction in Locally Advanced Cervical Cancer: Is it Feasible??

Prospective comparative study of dose dense neo-adjuvant chemotherapy followed by chemo-radiation and definitive chemoradiation

Transcription:

ESTRO Teaching Course on Image-guided radiotherapy & chemotherapy in gynaecological cancer - With a special focus on adaptive brachytherapy Florence, Italy 28 September -2 October 2014 Course Directors : Christine Haie-Meder, Radiation Oncologist, Institut Gustave Roussy, Villejuif (FRA) Richard Pötter, Radiation Oncologist, medical University Hospital, Vienna (AUT) Teaching Staff : Daniel Berger, Physicist, Medical University Hospital, Vienna (AUT) Umesh Mahantshetty, Radiation Oncologist, Tata Memorial Hospital, Mumbai (IND) Primoz Petric, Radiation Oncologist, National Centre for Cancer Care and Research, Doha, Qatar (QAT) Johannes Dimopoulos, Radiation Oncologist, Metropolitan Hospital, Athens (GRE) Taran Paulsen-Hellebust, Physicist, DNR Norwegian Radium Hospital, Oslo (NOR) Ina Jürgenliemk-Schulz, Radiation Oncologist, Medical Center Utrecht (NLD), Peter Petrow, Radiologist, Institut Curie, Paris (FRA) Kari Tanderup, Physicist, University Hospital, Århus (DEN) Guest Lecturer: n.n, MD, Radiation Oncologist, Florence (ITA) Local Organiser: Lorenzo Livi, Radiation Oncologist, University of Firenze, Florence (ITA) ESTRO coordinators: Melissa Vanderijst and Marta Jayes, project managers (BEL)

Day 1- Sunday 28 September Anatomy, pathology and imaging of the female pelvis and of gynaecologic malignancies CTV, PTV, OAR assessment and treatment planning EBRT Contouring workshops for CTV and OAR in EBRT Chair: 08.30 08.45 (15min) Welcome address 08.45-09.15 (30min) Anatomical considerations, role of clinical gynaecological examination, and staging 09.15-10.00 (45min) 3D Image based normal anatomy: uterus, parametria, organs at risk and nodes US, CT, MRI 10.00-10.30 Coffee Break Chair: Radiologic pathology of gynaecologic tumours (incl. nodes) : 10.30-11.20 (50min) At time of diagnosis At time of brachytherapy 11.20 11.35 (15min) Imaging protocols MRI and CT: patient preparation for EBRT and BT planning 11.35 12.00 (25min) Histologic and molecular pathology of gynaecologic malignancies 12.00 12.35 (35min) CTV contouring in EBRT 12.35-13.50 Lunch N.N P. Petrow P. Petrow J. Dimopoulos N.N, (pathologist) Chair: 13.50-14.35 (45min) Image guidance and PTV 14.35 15.05 (30min) Treatment techniques EBRT physics aspects T. Paulsen- Hellebust 15.05 15.35 (30min) Clinical evidence for EBRT techniques and medical dose constraints including DVH parameters 15.35 16.00 Coffee break 16.00-17.15 (75min) EBRT workshops for MDs: Clinical Target Volume (Nodal) and organs at risk [15 Introduction, 30 Contouring, 30 discussion ] 16:00 17:15 (75min) Plenary session for Physicists (frontal presentations) CTV and organs at risk contouring (one physician in the room) T. Paulsen- Hellebust N.N. (physician)

Day 2 - Monday 29 September Topic Case discussion, clinical results, treatment strategies for EBRT ±chemotherapy in gynaecological malignancies BT: cervix cancer techniques, GTV Diag, GTV Res, CTV Diag, CTV Adapt Tumor Imaging and clinical diagrams 08.30-09.30 (60min) Chair: Case Presentation plenary and case discussion in groups: *cervix cancer, squamous cell carcinoma, FIGO IB1, pelvic node *uterine endometroid adenocarcinoma (IB, Grade 2, 65 years) - 6 different discussion groups each with a group proposal - Parallel session (one break out room): Physics discussion session: EBRT image guidance 09.30-10.10 (40min) Cervix Cancer: Results of clinical trials including chemotherapy J. Dimopoulos 10.10-10.40 Coffee break 10.40-11.10 (30min) 11.10-12.00 (50min) 12.00-13.15 Chair: Endometrium Cancer: Techniques and clinical evidence for post-op. EBRT. Results of clinical trials in low/intermediate-risk patients Plenary case discussion (cervix cancer IB1, uterine ca. IB G2) based on group proposals (morning session) and trial results Lunch (Video viewing plenary, IGABT (I), 20 minutes) Chair: 13.15-13.45 (30min) Role of chemo/chemo-radiation in high-risk endometrium cancer 13:45-14:40 (55min) ICRU-GEC-ESTRO recommendation: GTV, CTVs at diagnosis and at time of brachytherapy for cervix cancer 14.40 15:10 (30min) Cervix cancer BT techniques: Fletcher/Manchester, Tandem/Ring, Moulage technique and limitations using standard loading patterns 15.10 15.40 (30min) Interstitial techniques for cervix cancer J. Dimopoulos 15.40-16.10 Coffee break Chair: 16.10 16.30 (20min) Clinical diagrams: Cervix cancer and vaginal disease 16:30 17:00 (30min) Results and analysis of homework delineation examples

Day 3 - Tuesday 30 September IGABT: OAR delineation, applicator reconstruction, Dose volume reporting, BT techniques (vagina, vulva, endometrium) Workshops: Contouring (MDs), Applicator reconstruction (Physicists) Chair: 08.30 09.15 (45min) Delineation of organs at risk (EBRT and IGABT) 09.15 10.00 (45min) Applicator reconstruction using Sectional Imaging 10.00 10.30 Coffee break Chair: 10.30 11.30 (60min) ICRU-GEC-ESTRO recommendations on dose volume reporting 11.30 12.30 Lunch (Video viewing plenary, IGABT (II), 20 minutes) Chair: 12.30 13.10 (40min) Endometrium cancer:target volumes and BT techniques 13.10 14.10 (60min) General and Image guided adaptive treatment strategies and BT techniques for vaginal and vulvar disease: 14.10-14.40 Coffee break 14.40 16.40 (120min) Workshops for MDs: cervix large-good response MRI/CT Special introduction into CT based contouring (U Mahantshetty) Workshops for Physicists: Reconstruction exercises in groups (Varian, Nucletron, Bebig)

Day 4 - Wednesday 01 October IGABT Treatment planning, physics, biology, clinical strategies Uncertainties, imaging and several BT fractions Nodal boost (EBRT), parametrial boost (IGABT, EBRT) Workshops: Contouring (MDs), Treatment Planning (Physicists) Chair: 08.30 08.50 (20min) Basic physics and dose planning principles 08.50 09.15 (25min) Radiobiological models to combine dose from external beam and brachytherapy (HDR, PDR) 09.15 10.00 (45min) Medical aspects of treatment planning and dose constraints 10.00 10.30 Coffee break Chair: 10.30 11.00 (30min) Physics aspects of treatment planning in endometrium cancer 11.00 11.45 (45min) 11.45 12.15 (30min) 12.15 13.30 Physics aspects of treatment planning intracavitary +/- interstitial techniques in cervix cancer Physics aspects of treatment planning interstitial techniques in vagina and vulva cancer Lunch (Video viewing plenary, IGABT (III), 20 minutes) 13.30 14.10 (40min) Chair: Inter- and intra-fraction uncertainties and imaging strategies (MRI/CT) in brachytherapy 14.10 14.40 (30min) Nodal boost: techniques, contribution of brachytherapy -> Ina? 14.40 15.10 (30min) Parametrial boost and midline block: combination of EBRT and IGABT 15.10 15.40 Coffee break Workshops for MDs: cervix large-bad response CT/MRI 15.40 17.00 (80min) Workshops for Physicists: Treatment planning in groups (Varian, Nucletron, Bebig)

Day 5 - Thursday 02 October IGABT: Practical excercises treatment planning Clinical outcome, Morbidity and QoL, Practical implementation of IGABT Interactive feedback session 08.30-09.00 (30min) Chair: Practical exercise for comprehensive dose reporting based on Excel-sheet including the LQ model 09.00-10.30 (90min) Cervix cancer: treatment planning workshop All teachers 10.30 11.00 Coffee break 11.00 11.45 (45min) 11.45 13.00 13.00 14.00 (60min) Chair: Morbidity and QoL outcome after IGABT: Rectum, sigmoid, bowel, bladder and vagina Lunch (Video viewing plenary, IGABT, local anaesthesia, 20 min) Chair: Disease Control after IGABT: Local control, lymph-node control, systemic control 14.00 14.45 (45min) Practical implementation - Tips and tricks 14.45 15.00 (15min) EMBRACE and GYN network 15.00 16:00 (60min) Interactive Feedback session: What have you learnt from this course? 16:00 Final Remarks and Closure of the Course J. Dimopoulos, K. Kirchheiner (psycho-oncologist) J. Dimopoulos